DAIC
APRIL 6, 2024
However, researchers said the drug may be helpful in reducing heart failure risks, including hospitalization, following a heart attack. The study enrolled 6,522 people treated for acute myocardial infarction at 451 centers in 22 countries. About 32% had Type 2 diabetes.
Dr. Sanjay Gupta
DECEMBER 19, 2022
If the inflammation spreads to the surface of the heart itself, it is termed myopericarditis. About 5% of patients who present to A+E with chest pain which is not deemed to be a heart attack or angina are ultimately diagnosed with pericarditis. Also recent cardiac surgery and a recent heart attack can present with pericarditis.
DAIC
APRIL 6, 2024
While composite of death and heart failure hospitalizations was not significantly reduced, empagliflozin may help reduce heart failure risks after a heart attack, according to results from the EMPACT-MI trial presented on day one of the American College of Cardiology Scientific Sessions, ACC.24,
Dr. Sanjay Gupta
MAY 23, 2022
Today’s vlog is on the subject of heart failure and in particular on a special type of pacemaker which can make a significant improvement to the quality of life and length of life in patients with heart failure. What is heart failure?
Dr. Sanjay Gupta
MARCH 6, 2022
Heart failure is a chronic clinical syndrome characterised by the inability of the heart to pump out enough blood to meet the body’s requirements. Heart failure is one of the most researched conditions in all of medicine and happily we now have lots of very beneficial therapies which can improve both quality of life and prognosis.
Dr. Malcolm Kendrick
OCTOBER 20, 2023
The aim is to reduce death and damage from nasty things such as heart attacks and strokes. With diabetes, the aim is also to reduce heart attacks and strokes… additionally kidney failure, and amputations, and blindness. Currently, after any heart attack, standard therapy includes four different medications.
Expert insights. Personalized for you.
98 
Let's personalize your content